See Program materials.

By the end of the session the participant will be able to:

• Describe the best therapy for mild COVID-19 treated out of the hospital
• Describe characteristics of the Delta variant including transmissibility and severity of illness
• Describe the protean neurological presentations and long-haul sequelae of COVID-19 infections
• Define the importance of COVID-19 in the public health arena
• Identify appropriated decision-making as to when to use corticosteroids and new biologic modifiers for patients hospitalized with COVID-19

ACCME Activity #201805122

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

Faculty Disclosures: Michael S. Niederman, M.D., MACP, FCCP, FCCM, FERS, Professor of Clinical Medicine, Weill Cornell Medical College, has received financial compensation from Abbvie, Gilead, Pfizer, Merck for consulting work.

Faculty Disclosures: Shira C. Shafir, Ph.D., MPH, Associate Professor Department of Epidemiology, UCLA Fielding School of Public Health, has no relevant financial disclosures.

Faculty Disclosures: George Sarka MD, DrPH, MPH, Associate Clinical Professor in Medicine at UCLA, has received financial compensation from Abbvie for being on a speaker’s bureau.

Faculty Disclosures: Paul Simon, M.D., M.P.H., Assistant Director, Los Angeles County Department of Public Health, has no relevant financial disclosures.

Disclosures of Educational Planners: George Sarka MD, DrPH, MPH, Associate Clinical Professor in Medicine at UCLA, has received financial compensation from Abbvie for being on a speaker’s bureau.

Disclosures of Moderator: Stuart Bussey, MD, President, UAPD, has no relevant financial disclosures.

• Read the learning objectives above
• Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
• View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
• Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
• Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

*Required to view Printable PDF Version